{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:02:23Z","timestamp":1791514943656,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013220","name":"Ultragenyx Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016915","name":"Inventiva Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ymgme.2020.01.003","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T11:15:08Z","timestamp":1578741308000},"page":"219-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII"],"prefix":"10.1016","volume":"129","author":[{"given":"Raymond Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Francisco","family":"da Silva Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"L\u00f3pez-Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon Reid","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Cimms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Jurecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2020.01.003_bb0005","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/adc.72.3.263","article-title":"The mucopolysaccharidoses: a clinical review and guide to management","volume":"72","author":"Wraith","year":"1995","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0015","first-page":"511","article-title":"Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome)","volume":"30","author":"Tomatsu","year":"2009","journal-title":"HumMutat"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Montano","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2017.10","article-title":"Quantitative clinical characteristics of 53 patients with MPS VII: a cross-sectional analysis","author":"Zielonka","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0030","first-page":"1","article-title":"Vestronidase Alfa: a review in mucopolysaccharidosis VII","author":"McCafferty","year":"2019","journal-title":"BioDrugs"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2014.10.017","article-title":"First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient","volume":"114","author":"Fox","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0040","first-page":"S59","article-title":"Enzyme replacement therapy (ERT) for mucopolysaccharidosis VII (MPS VII; Sly syndrome) reduces lysosomal storage in a 36-week phase 1\/2 clinical study","volume":"114","author":"Jones","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2020.01.003_bb0045","first-page":"395","article-title":"A novel blind start study design to investigate vestronidase alfa for mucopolysaccharidosis VII, an ultra-rare genetic disease","volume":"150","author":"Harmatz","year":"2007","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2020.01.003_bb0050","first-page":"53","article-title":"Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study population","volume":"49","author":"Haller","year":"2019","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2006.12.052","article-title":"Six-minute walk test in children and adolescents","volume":"150","author":"Geiger","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0060","first-page":"126","article-title":"The PedsQL: measurement model for the pediatric quality of life inventory","volume":"37","author":"Varni","year":"1999","journal-title":"MedCare"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0065","first-page":"1502","article-title":"Pulmonary function growth velocity in children 6 to 18\u00a0years of age","volume":"148","author":"Wang","year":"1993","journal-title":"AmRevRespirDis"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1164\/ajrccm.163.3.2002054","article-title":"Spirometric pulmonary function in healthy preschool children","volume":"163","author":"Eigen","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0080","series-title":"Bruininks-Oseretsky Test of Motor Proficiency 2nd edition manual. 2nd edition manual ed","author":"Bruininks","year":"2005"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0085","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1164\/ajrccm.155.4.9105067","article-title":"Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients","volume":"155","author":"Redelmeier","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0090","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1183\/09031936.00140507","article-title":"Interpretation of treatment changes in 6-min walk distance in patients with COPD","volume":"32","author":"Puhan","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0095","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1164\/rccm.201007-1179OC","article-title":"Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference","volume":"183","author":"du Bois","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1164\/rccm.201203-0480OC","article-title":"The minimal important difference in the 6-min walk test for patients with pulmonary arterial hypertension","volume":"186","author":"Mathai","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0115","first-page":"465","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"GenetMed"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Arch-Ophthalmol","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","article-title":"New visual acuity charts for clinical research","volume":"94","author":"Ferris","year":"1982","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1475-1313.1993.tb00421.x","article-title":"Reliability of high- and low-contrast letter charts","volume":"13","author":"Reeves","year":"1993","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ridd.2008.12.002","article-title":"Reliability and responsiveness of the Bruininks-Oseretsky test of motor proficiency-second edition in children with intellectual disability","volume":"30","author":"Wuang","year":"2009","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpeds.2016.08.033","article-title":"Outcomes of long-term treatment with laronidase in patients with mucopolysaccharidosis type I","volume":"178","author":"Laraway","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.36584","article-title":"Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)-10-year follow-up of patients who previously participated in an MPS VI survey study","author":"Giugliani","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0160","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10545-014-9686-7","article-title":"Long-term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case series","volume":"37","author":"Lampe","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1177\/2326409818755800","article-title":"Long-term galsulfase treatment associated with improved survival of patients with mucopolysaccharidosis VI (maroteaux-lamy syndrome) 15-year follow-up from the survey study","volume":"6","author":"Quartel","year":"2018","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/21678707.2015.1017469","article-title":"Enzyme replacement therapy: lessons learned and emerging questions","volume":"3","author":"Jurecka","year":"2015","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymgme.2020.01.003_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2017.05.005","article-title":"Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: a review of the literature","volume":"121","author":"Janzen","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/rej.2009.0920","article-title":"New strategies for enzyme replacement therapy for lysosomal storage diseases","volume":"13","author":"Grubb","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.08.009","article-title":"Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations\u2014neurological signs and symptoms","volume":"122","author":"Shapiro","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jcpt.12136","article-title":"Current and potential therapeutic strategies for mucopolysaccharidoses","volume":"39","author":"Noh","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3174\/ajnr.A2832","article-title":"Brain and spinal MR imaging findings in mucopolysaccharidoses: a review","volume":"34","author":"Zafeiriou","year":"2013","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0200","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ymgme.2012.08.013","article-title":"Effect of rapid cessation of enzyme replacement therapy: a report of 5 cases and a review of the literature","volume":"107","author":"Jurecka","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.01.003_bb0205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2013.08.019","article-title":"Effect of rapid cessation of enzyme replacement therapy: a report of 5 more cases","volume":"111","author":"Jurecka","year":"2014","journal-title":"Mol. Genet. Metab."}],"updated-by":[{"DOI":"10.1016\/j.ymgme.2020.08.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000}}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219307851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219307851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:24:05Z","timestamp":1761089045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219307851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1096719219307851"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.01.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}